SLCO2B1 and posterior cortical atrophy: SLCO2B1 has been shown to be significantly increased in metastatic tissue, compared to primary tissue in PCa [21], and polymorphisms of SLCO2B1 gene is associated with shorter time to progression and overall survival (OS) in patients with metastatic PCa receiving androgen deprivation therapy [17, 22].